A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their commitment and lasting impact at the organization. This year, Fred Hutch is ...

New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune ...

When Jacqueline Woodfork got sick, the ER physicians found a mass in her chest that turned out to be thymic carcinoma.

As chief medical officer, Tom Purcell, MD, MBA, is overseeing an organization-wide initiative to improve the delivery of care ...

Screening is an effective tool for reducing the burden of cancer,” per Fred Hutch public health researcher Chris Li. “But it's a complex process with multiple steps." Unfortunately, many Americans are ...

A cancer diagnosis always brings challenges and uncertainty. But for those diagnosed with so-called “rare” cancers — traditionally described as diseases that affect 40,000 or fewer Americans every ...

Affiliate Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch Affiliate Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred ...

Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...

Bisphosphonates are popular bone-targeting drugs. Older people take them to prevent and treat osteoporosis. Breast cancer patients, particularly those with metastatic disease, take them to prevent and ...